
GALT Market Cap & Key Metrics
Galectin Therapeutics Inc.
$2.91
-$0.11(-3.64%)
32
Overall
40
Value
30
Tech
26
Quality
Market Cap
$293.47M
Volume
262.80K
52W Range
$2.03 - $7.13
Target Price
$11.00
GALT market cap is $293.47M. This page lists Galectin Therapeutics Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
GALT Key Metrics
- Market cap
- $293.47M
- EPS estimate, current year
- $-0.30
- EPS growth, 3-year
- +0.00%
- Value score
- 40
- Quality score
- 26
- Technical score
- 30
| Fiscal year | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|
| EBITDA | -$19.97M | -$15.78M | -$12.08M | -$9.67M | -$10.91M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GALT | $2.91 | -3.6% | 262.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Galectin Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW